In conclusion, the identification of the previously unreported FGFR3-FASN gene fusion offers novel insights into molecular events potentially linked to early recurrence in GBM and highlights the potential involvement of lipid metabolism in GBM biology. The gene discussed is FGFR3; the disease is glioblastoma.